Search

everythinglearnresearchcommunity

for

Search:↓

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Tislelizumab can cause cutaneous lupus erythematosus.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Syphilis can cause unexpected symptoms like hair loss in well-managed HIV patients, so doctors should stay alert.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Goats infested with lice showed anemia and skin issues, which improved after treatment.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Rituximab improved her dermatomyositis better than usual treatments.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.